Eli Casdin
CIK: 0001534264
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 18, 2026LAB
STANDARD BIOTOOLS INC.
Award(A)Direct99.1K shares- - Jun 18, 2026WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
4.2K shares- - Jun 18, 2026WGS
GeneDx Holdings Corp.
Exercise(M)Direct3.6K shares- - Feb 26, 2026LAB
STANDARD BIOTOOLS INC.
Award(A)Direct53K shares at avg. $1.17$62K - Jun 20, 2025LAB
STANDARD BIOTOOLS INC.
Award(A)Direct94.6K shares- - Jun 18, 2025WGS
GeneDx Holdings Corp.
Exercise(M)Direct12.9K shares- - Jun 18, 2025WGS
GeneDx Holdings Corp.
Award(A)DirectRestricted Stock Unit
3.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  LAB STANDARD BIOTOOLS INC. | Award(A) | 99,116 | - | $0 | Direct |
| Jun 18, 2026 |  WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 4,248 | - | - | Direct |
| Jun 18, 2026 | WGS GeneDx Holdings Corp. | Exercise(M) | 3,576 | - | $0 | Direct |
| Feb 26, 2026 | LAB STANDARD BIOTOOLS INC. | Award(A) | 52,991 | $1.17 | $61,999 | Direct |
| Jun 20, 2025 | LAB STANDARD BIOTOOLS INC. | Award(A) | 94,592 | - | - | Direct |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Exercise(M) | 12,924 | - | - | Direct |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | Award(A) Restricted Stock Unit | 3,576 | - | - | Direct |
1-7 of 7 transactions
About Casdin Eli
Casdin Eli (SEC CIK 0001534264) files insider reports with the SEC as Director of STANDARD BIOTOOLS INC. (LAB) and Director of GeneDx Holdings Corp. (WGS).
Signal8 holds 6 ownership filings by Casdin Eli, all Form 4s, filed between Jun 23, 2025 and Jun 23, 2026. Those filings report 7 transactions, from Jun 18, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Casdin Eli's filings is in STAMFORD, CT.
Recent filings by Casdin Eli
- Jun 18, 2026: Grant or award of LAB shares (Form 4, code A).
- Jun 18, 2026: Grant or award of WGS derivative securities (Form 4, code A).
- Jun 18, 2026: Option exercise of WGS shares (Form 4, code M).
- Feb 26, 2026: Grant or award of LAB shares (Form 4, code A).
- Jun 20, 2025: Grant or award of LAB shares (Form 4, code A).
Other insiders filing for STANDARD BIOTOOLS INC. (LAB)
- Mackay Sean, SVP & Chief Business Officer
- Kim Hanjoon Alex, Chief Financial Officer
- Egholm Michael, President & CEO
- Carey Thomas D., Director
- Witney Frank, Director
- Cox Troy, Director